Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL
- Status
- COMPLETED
- Phase
- PHASE2
Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
- Status
- TERMINATED
- Phase
- NA
Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
- Status
- TERMINATED
- Phase
- NA
S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
- Status
- TERMINATED
- Phase
- PHASE2
American Ginseng in Treating Patients With Fatigue Caused by Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction
- Status
- COMPLETED
- Phase
- NA
PET Study in Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A